Our 2025 Impact Report is Live — See what we are building together >

Press Releases

HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders

May 17, 2018 | By

Share :